IsoPlexis Corp
NASDAQ:ISO
IsoPlexis Corp
Capital Expenditures
IsoPlexis Corp
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IsoPlexis Corp
NASDAQ:ISO
|
Capital Expenditures
-$7.8m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Capital Expenditures
-$1.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-16%
|
|
Danaher Corp
NYSE:DHR
|
Capital Expenditures
-$1.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Capital Expenditures
-$99.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
Agilent Technologies Inc
NYSE:A
|
Capital Expenditures
-$358m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-7%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Capital Expenditures
-$630m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-24%
|
See Also
What is IsoPlexis Corp's Capital Expenditures?
Capital Expenditures
-7.8m
USD
Based on the financial report for Dec 31, 2022, IsoPlexis Corp's Capital Expenditures amounts to -7.8m USD.
What is IsoPlexis Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-53%
Over the last year, the Capital Expenditures growth was 68%. The average annual Capital Expenditures growth rates for IsoPlexis Corp have been -53% over the past three years .